Targeted inhibition of osteoclastogenesis reveals the pathogenesis and therapeutics of bone loss under sympathetic neurostress.
Sui B, Liu J, Zheng C, Dang L, Chen J, Cao Y, Zhang K, Liu L, Dang M, Zhang L, Chen N, He T, Xuan K, Jin F, Zhang G, Jin Y, Hu C.
Sui B, et al. Among authors: jin f, jin y.
Int J Oral Sci. 2022 Aug 1;14(1):39. doi: 10.1038/s41368-022-00193-1.
Int J Oral Sci. 2022.
PMID: 35915088
Free PMC article.